Altimmune, Inc. Equity Distribution Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2025
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2024
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2023
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2022
Altimmune, Inc. Equity Distribution Agreement with Piper Sandler & Co., Evercore Group L.L.C., and B. Riley Securities, Inc.
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
NY
2021
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2021
Altimmune, Inc. $50,000,000 Equity Distribution Agreement with JMP Securities LLC (March 27, 2020)
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2020
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2020
Altimmune, Inc. Restricted Stock Agreement under 2017 Omnibus Incentive Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Altimmune, Inc. Restricted Stock Agreement under 2018 Inducement Grant Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Controlled Equity Offering Sales Agreement between PharmAthene, Inc. and Cantor Fitzgerald & Co. (March 25, 2013)
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
NY
2013
Pharmathene, Inc. Restricted Stock Agreement under 2007 Long-Term Incentive Compensation Plan
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2011